678 related articles for article (PubMed ID: 32479989)
21. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 36166247
[TBL] [Abstract][Full Text] [Related]
22. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
Yamasaki K; Suzuki H; Yasutake J; Yamazaki Y; Suzuki Y
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
[TBL] [Abstract][Full Text] [Related]
23. Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA
Chiu YL; Lin WC; Shu KH; Fang YW; Chang FC; Chou YH; Wu CF; Chiang WC; Lin SL; Chen YM; Wu MS
Front Immunol; 2021; 12():638309. PubMed ID: 34177889
[TBL] [Abstract][Full Text] [Related]
24. Galactose-Deficient IgA1 Deposits in Clear Cell Renal Cell Carcinoma-Related Henoch-Schönlein Purpura Nephritis.
Zhao Y; Kim Y; Junghare M; Vakil V; Su X; Li F; Bu L
Case Rep Nephrol; 2020; 2020():8828336. PubMed ID: 32908737
[TBL] [Abstract][Full Text] [Related]
25. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
Zheng N; Xie K; Ye H; Dong Y; Wang B; Luo N; Fan J; Tan J; Chen W; Yu X
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699192
[TBL] [Abstract][Full Text] [Related]
26. The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition.
Tang X; Zheng J; Jiang X; Wan F; Hou X; Liu S; Zhang M; Song Y; Ye T; Yu J
Int Urol Nephrol; 2023 Aug; 55(8):2119-2129. PubMed ID: 36849627
[TBL] [Abstract][Full Text] [Related]
27. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
[TBL] [Abstract][Full Text] [Related]
28. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
29. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy.
Wang M; Lv J; Zhang X; Chen P; Zhao M; Zhang H
Kidney Int Rep; 2020 Feb; 5(2):165-172. PubMed ID: 32043030
[TBL] [Abstract][Full Text] [Related]
30. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
Yanagawa H; Suzuki H; Suzuki Y; Kiryluk K; Gharavi AG; Matsuoka K; Makita Y; Julian BA; Novak J; Tomino Y
PLoS One; 2014; 9(5):e98081. PubMed ID: 24858067
[TBL] [Abstract][Full Text] [Related]
31. Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.
Karasawa K; Iwabuchi Y; Kyoda M; Akihisa T; Yamaguchi E; Suzuki S; Ogura S; Takabe T; Miyabe Y; Kamiyama T; Nakano M; Manabe S; Kamiyama M; Akiyama K; Sato M; Uchida K; Nitta K; Moriyama T
Intern Med; 2019 Sep; 58(17):2551-2554. PubMed ID: 31178497
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
[TBL] [Abstract][Full Text] [Related]
33. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
Hastings MC; Moldoveanu Z; Julian BA; Novak J; Sanders JT; McGlothan KR; Gharavi AG; Wyatt RJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2069-74. PubMed ID: 20634323
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
Elíasdóttir S; Khramova A; Saeed A; Guron G; Boi R; Mölne J; Ebefors K; Nyström J
BMC Nephrol; 2023 Jun; 24(1):160. PubMed ID: 37286948
[TBL] [Abstract][Full Text] [Related]
35. Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change.
Cho WH; Park SH; Choi SK; Jung SW; Jeong KH; Kim YG; Moon JY; Lim SJ; Sung JY; Jhee JH; Chin HJ; Choi BS; Lee SH
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32806730
[TBL] [Abstract][Full Text] [Related]
36. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
[TBL] [Abstract][Full Text] [Related]
37. Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.
Fukao Y; Suzuki H; Kim JS; Jeong KH; Makita Y; Kano T; Nihei Y; Nakayama M; Lee M; Kato R; Chang JM; Lee SH; Suzuki Y
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683557
[TBL] [Abstract][Full Text] [Related]
38. Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.
Ishiko S; Tanaka A; Takeda A; Hara M; Hamano N; Koizumi M; Ueno T; Hayashi H; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Horinouchi T; Yamamura T; Ninchoji T; Shima Y; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
Clin Exp Nephrol; 2021 Jul; 25(7):779-787. PubMed ID: 33743099
[TBL] [Abstract][Full Text] [Related]
39. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
He H; Shen M; Tang Y; Sun W; Xu X
Altern Ther Health Med; 2024 Jan; 30(1):419-425. PubMed ID: 37820669
[TBL] [Abstract][Full Text] [Related]
40. IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
Hastings MC; Rizk DV; Kiryluk K; Nelson R; Zahr RS; Novak J; Wyatt RJ
Pediatr Nephrol; 2022 Apr; 37(4):719-733. PubMed ID: 33818625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
